Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing

Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing

US Patent 8883753 · Granted Nov 11, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune di2025
Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune di2025
Method to identify subjects at higher risk to develop an autoimmune disease base2025
Soluble interleukin-7 receptor (sIL7R) modulating therapy to treat autoimmune di2023
Method of isolating circulating tumor cells2023
Soluble interleukin-7 receptor (sIL7R) modulating therapy to treat autoimmune di2021
Method to identify subjects at higher risk to develop an autoimmune disease base2021
Method of isolating circulating tumor cells2018
Synthetic regulation of gene expression2017
Methods and compositions for synthesis of nucleic acid molecules using multiple 2016
Synthetic regulation of gene expression2016
Methods and compositions for synthesis of nucleic acid molecules using multipler2015